Введение
На этой странице представлен всесторонний анализ известной истории инсайдерской торговли Amit Sachdev. Инсайдеры — это должностные лица, директора или крупные инвесторы компании. Инсайдерам запрещено совершать сделки в своих компаниях на основе конкретной, закрытой информации. Это не означает, что для них незаконно совершать какие-либо сделки в своих собственных компаниях. Однако они должны сообщать обо всех сделках в SEC по форме 4. Несмотря на эти ограничения, академические исследования показывают, что инсайдеры в целом имеют тенденцию опережать рынок в своих собственных компаниях.
Средняя прибыльность торговли
Средняя прибыльность торговли — это средний доход от всех покупок на открытом рынке, сделанных инсайдером за последние три года. Чтобы рассчитать это, мы проверяем каждую незапланированную покупку инсайдера на открытом рынке, исключая все сделки, которые были отмечены как часть торгового плана 10b5-1. Затем мы рассчитываем среднюю эффективность этих сделок за 3, 6 и 12 месяцев, усредняя каждую из этих продолжительностей, чтобы получить окончательный показатель эффективности для каждой сделки. Наконец, мы усредняем все показатели производительности, чтобы рассчитать показатель производительности для инсайдера. В этот список включены только инсайдеры, совершившие не менее трех сделок за последние два года.
Если прибыльность этой инсайдерской сделки равна «Н/Д», то инсайдер либо не совершал никаких покупок на открытом рынке за последние три года, либо совершенные им сделки слишком недавние, чтобы можно было рассчитать надежные показатели эффективности.
Частота обновлений: ежедневно
Компании с заявленной инсайдерской позицией
В документах SEC указано, что Amit Sachdev сообщил о владениях или сделках со следующими компаниями:
Безопасность | Заголовок | Последние зарегистрированные холдинги |
---|---|---|
US:VRTX / Vertex Pharmaceuticals Incorporated | EVP Chief Patient & Ext Af Off | 68 490 |
US:EIGR / Eiger BioPharmaceuticals, Inc. | Director | 12 000 |
Как интерпретировать графики
На следующих диаграммах показаны динамика акций ценных бумаг после каждой незапланированной сделки на открытом рынке, совершенной Amit Sachdev. Незапланированная сделка — это сделка, которая не была совершена в рамках торгового плана 10b5-1. Динамика акций отображается как совокупное процентное изменение цены акций. Например, если инсайдерская сделка была совершена 1 января 2019 года, на графике будет показано дневное процентное изменение ценной бумаги к текущему дню. Если бы цена акций за это время выросла с 10 до 15 долларов, совокупное процентное изменение цены акций составило бы 50%. Изменение цены с 10 до 20 долларов составит 100%, а изменение цены с 10 до 5 долларов составит -50%.
В конечном счете, мы пытаемся определить, насколько тесно инсайдерские сделки коррелируют с избыточной доходностью (положительной или отрицательной) от цены акций, чтобы увидеть, рассчитывает ли инсайдер свои сделки для получения прибыли от инсайдерской информации. Рассмотрим ситуацию, когда это делал инсайдер. В этой ситуации мы ожидаем либо (а) положительной прибыли после покупок, либо (б) отрицательной прибыли после продажи. В случае (а) график ПОКУПКИ покажет серию восходящих кривых, указывающих на положительную доходность после каждой транзакции покупки. В случае (b) график ПРОДАЖИ будет отображать серию нисходящих кривых, указывающих на отрицательную доходность после каждой транзакции продажи.
Однако одного этого недостаточно, чтобы делать выводы. Если, например, цена акций компании росла нециклически в течение многих лет, то мы ожидаем, что все графики после покупки будут иметь наклон вверх. Аналогичным образом, нециклическое снижение на протяжении многих лет приведет к нисходящему наклону постторговых графиков. Ни один из этих графиков не указывает на инсайдерскую торговую активность.
Самым сильным индикатором была бы ситуация, когда цена акций была чрезвычайно цикличной, и были как положительные сигналы на графике ПОКУПКИ, так и отрицательные участки на графике ПРОДАЖИ. Эта ситуация весьма наводит на мысль о том, что инсайдер рассчитывает сделку в свою финансовую выгоду.
История инсайдерской торговли
В этой таблице показан полный список инсайдерских сделок, совершенных Amit Sachdev, раскрытый Комиссии по ценным бумагам и биржам (SEC).
Дата файла | Тран Дата | Форма | Бегущая строка | Безопасность | Код | Акции | Оставшиеся акции | Процент Изменять |
Делиться Цена |
Тран Ценить |
Оставшийся Ценить |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -3 703 | 68 490 | -5,13 | 479,61 | -1 775 996 | 32 848 489 | |
2025-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 470 | 72 193 | -3,31 | 483,28 | -1 193 702 | 34 889 433 | |
2025-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 139 | 74 663 | -2,79 | 463,46 | -991 341 | 34 603 314 | |
2025-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 211 | 76 802 | 8,80 | ||||
2025-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 056 | 70 591 | -2,83 | 467,98 | -962 167 | 33 035 176 | |
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 114 | 72 647 | 10,86 | ||||
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 210 | 65 533 | 14,32 | ||||
2024-06-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
G - Gift | -4 600 | 0 | -100,00 | ||||
2024-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -32 | 55 325 | -0,06 | 430,93 | -13 790 | 23 841 202 |
2024-02-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 004 | 55 325 | -5,15 | 425,70 | -1 278 803 | 23 551 852 |
2024-02-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 469 | 58 329 | -4,06 | 431,79 | -1 066 090 | 25 185 879 | |
2024-02-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 191 | 60 798 | -4,99 | 421,77 | -1 345 868 | 25 642 772 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 254 | 63 989 | -6,23 | 420,79 | -1 790 041 | 26 925 931 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 623 | 68 243 | -3,70 | 420,58 | -1 103 181 | 28 701 641 | |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -3 498 | 70 866 | -4,70 | 424,01 | -1 483 187 | 30 047 893 | |
2024-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 222 | 74 364 | -4,15 | 420,24 | -1 354 013 | 31 250 727 |
2024-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 022 | 77 586 | -2,54 | 422,74 | -854 780 | 32 798 706 | |
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 114 | 79 608 | 9,81 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 866 | 72 494 | 12,17 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 814 | 64 628 | 9,89 | ||||
2023-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -35 | 58 814 | -0,06 | 369,92 | -12 947 | 21 756 475 |
2023-08-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -10 031 | 58 814 | -14,57 | 350,00 | -3 510 850 | 20 584 900 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 468 | 66 518 | -3,58 | 289,12 | -713 548 | 19 231 684 | |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -3 498 | 68 986 | -4,83 | 292,85 | -1 024 389 | 20 202 550 | |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -4 657 | 72 484 | -6,04 | 298,26 | -1 388 997 | 21 619 078 | |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 611 | 77 141 | -3,27 | 294,33 | -768 496 | 22 704 911 | |
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 866 | 79 752 | 10,94 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 210 | 71 886 | 12,89 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 324 | 63 676 | 19,35 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
G - Gift | -1 672 | 11 052 | -13,14 | ||||
2022-03-11 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 12 000 | 12 000 | |||||
2022-03-11 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Common Stock |
A - Award | 6 000 | 16 000 | 60,00 | ||||
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -7 368 | 48 210 | -13,26 | 227,86 | -1 678 872 | 10 985 131 | |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -3 497 | 55 578 | -5,92 | 232,51 | -813 087 | 12 922 441 | |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 491 | 59 075 | -4,05 | 237,74 | -592 210 | 14 044 490 | |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 210 | 61 566 | 15,39 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 628 | 53 356 | 27,87 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 800 | 41 728 | 30,69 | ||||
2021-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -30 | 31 928 | -0,09 | 187,48 | -5 624 | 5 985 861 |
2021-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -21 | 31 958 | -0,07 | 186,78 | -3 922 | 5 969 115 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 | 40 133 | -0,01 | 217,27 | -1 086 | 8 719 697 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -32 | 40 138 | -0,08 | 216,40 | -6 925 | 8 685 863 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -8 | 40 170 | -0,02 | 215,59 | -1 725 | 8 660 250 |
2021-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -3 884 | 0 | -100,00 | ||||
2021-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 40 133 | -0,50 | 217,69 | -43 538 | 8 736 553 |
2021-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 338 | 40 333 | -3,21 | 216,67 | -289 904 | 8 738 951 |
2021-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 346 | 41 671 | -5,33 | 215,58 | -505 751 | 8 983 434 |
2021-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 884 | 44 017 | 9,68 | 86,52 | 336 044 | 3 808 351 | |
2021-03-15 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2021-03-15 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Common Stock |
A - Award | 5 000 | 10 000 | 100,00 | ||||
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 40 133 | -0,50 | 216,62 | -43 324 | 8 693 610 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -336 | 40 333 | -0,83 | 215,56 | -72 428 | 8 694 181 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -668 | 40 669 | -1,62 | 214,19 | -143 079 | 8 710 893 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 460 | 41 337 | -3,41 | 213,30 | -311 418 | 8 817 182 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -922 | 42 797 | -2,11 | 211,56 | -195 058 | 9 054 133 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 946 | 43 719 | -6,31 | 217,57 | -640 961 | 9 511 943 | |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -800 | 46 665 | -1,69 | 213,02 | -170 416 | 9 940 578 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 800 | 47 465 | -10,89 | 212,15 | -1 230 470 | 10 069 700 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 500 | 53 265 | -2,74 | 211,36 | -317 040 | 11 258 090 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 164 | 54 765 | -2,08 | 210,00 | -244 440 | 11 500 650 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -7 613 | 55 929 | -11,98 | 211,75 | -1 612 053 | 11 842 966 | |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 63 542 | -0,16 | 211,98 | -21 198 | 13 469 633 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 63 642 | -0,78 | 211,22 | -105 610 | 13 442 463 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 860 | 64 142 | -5,68 | 210,43 | -812 260 | 13 497 401 |
2021-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -2 421 | 68 002 | -3,44 | 214,16 | -518 481 | 14 563 308 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 627 | 70 423 | 19,78 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 324 | 58 796 | 21,30 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 126 | 48 472 | 26,41 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
G - Gift | -3 391 | 7 368 | -31,52 | ||||
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -8 | 35 103 | -0,02 | 224,44 | -1 796 | 7 878 517 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -22 | 35 111 | -0,06 | 223,76 | -4 923 | 7 856 437 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 | 35 133 | -0,03 | 222,50 | -2 670 | 7 817 092 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 941 | 3 884 | -33,32 | ||||
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -751 | 35 103 | -2,09 | 279,18 | -209 664 | 9 800 056 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -690 | 35 854 | -1,89 | 278,25 | -191 992 | 9 976 376 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 36 544 | -1,35 | 276,96 | -138 480 | 10 121 226 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 941 | 37 044 | 5,53 | 86,52 | 167 935 | 3 205 047 | |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -6 | 35 103 | -0,02 | 288,36 | -1 730 | 10 122 301 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -13 | 35 109 | -0,04 | 287,65 | -3 739 | 10 099 104 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -11 | 35 122 | -0,03 | 286,63 | -3 153 | 10 067 019 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -6 | 35 133 | -0,02 | 284,95 | -1 710 | 10 011 148 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 | 35 139 | -0,01 | 283,01 | -1 415 | 9 944 688 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 | 35 144 | -0,01 | 281,65 | -563 | 9 898 308 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -10 | 35 146 | -0,03 | 280,34 | -2 803 | 9 852 830 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 | 35 156 | 0,00 | 278,42 | -278 | 9 788 134 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 | 35 157 | -0,01 | 276,21 | -829 | 9 710 715 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 | 35 160 | 0,00 | 274,67 | -275 | 9 657 397 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -10 665 | 0 | -100,00 | ||||
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 35 103 | -0,28 | 286,72 | -28 672 | 10 064 732 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 367 | 35 203 | -3,74 | 285,94 | -390 880 | 10 065 946 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 314 | 36 570 | -5,95 | 285,15 | -659 837 | 10 427 936 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 100 | 38 884 | -2,75 | 283,98 | -312 378 | 11 042 278 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -913 | 39 984 | -2,23 | 282,89 | -258 279 | 11 311 074 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 398 | 40 897 | -3,31 | 281,74 | -393 873 | 11 522 321 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 817 | 42 295 | -4,12 | 280,77 | -510 159 | 11 875 167 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -655 | 44 112 | -1,46 | 279,67 | -183 184 | 12 336 803 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -201 | 44 767 | -0,45 | 277,38 | -55 753 | 12 417 470 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -800 | 44 968 | -1,75 | 276,25 | -221 000 | 12 422 410 |
2020-05-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 665 | 45 768 | 30,38 | 131,89 | 1 406 607 | 6 036 342 | |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -669 | 10 665 | -5,90 | ||||
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -669 | 35 103 | -1,87 | 275,28 | -184 162 | 9 663 154 |
2020-05-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 669 | 35 772 | 1,91 | 131,89 | 88 234 | 4 717 969 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -13 356 | 11 334 | -54,09 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 35 103 | -0,57 | 273,59 | -54 718 | 9 603 830 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -403 | 35 303 | -1,13 | 272,58 | -109 850 | 9 622 892 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 35 706 | -0,28 | 271,09 | -27 109 | 9 679 540 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -11 553 | 35 806 | -24,39 | 270,01 | -3 119 426 | 9 667 978 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 47 359 | -1,46 | 269,08 | -188 356 | 12 743 360 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 48 059 | -0,62 | 267,34 | -80 202 | 12 848 093 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 48 359 | -0,21 | 265,72 | -26 572 | 12 849 953 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 13 356 | 48 459 | 38,05 | 131,89 | 1 761 523 | 6 391 258 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 942 | 5 825 | -25,00 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -9 310 | 24 690 | -27,38 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -32 500 | 0 | -100,00 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 940 | 35 103 | -26,93 | 264,92 | -3 428 065 | 9 299 487 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -964 | 48 043 | -1,97 | 263,58 | -254 091 | 12 663 174 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -9 447 | 49 007 | -16,16 | 262,69 | -2 481 632 | 12 873 649 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 395 | 58 454 | -6,99 | 261,68 | -1 150 084 | 15 296 243 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -8 383 | 62 849 | -11,77 | 260,48 | -2 183 604 | 16 370 908 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -6 223 | 71 232 | -8,03 | 259,63 | -1 615 677 | 18 493 964 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 400 | 77 455 | -1,78 | 258,59 | -362 026 | 20 029 088 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 942 | 78 855 | 2,52 | 86,52 | 168 022 | 6 822 535 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 9 310 | 76 913 | 13,77 | 131,89 | 1 227 896 | 10 144 056 | |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 32 500 | 67 603 | 92,58 | 109,14 | 3 547 050 | 7 378 191 | |
2020-03-13 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2020-03-13 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Common Stock |
A - Award | 5 000 | 5 000 | |||||
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -540 | 32 915 | -1,61 | 238,33 | -128 698 | 7 844 632 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -180 | 33 455 | -0,54 | 236,63 | -42 593 | 7 916 457 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -360 | 33 635 | -1,06 | 235,75 | -84 870 | 7 929 451 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -533 | 33 995 | -1,54 | 234,56 | -125 020 | 7 973 867 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -90 | 34 528 | -0,26 | 233,18 | -20 986 | 8 051 239 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -450 | 34 618 | -1,28 | 232,62 | -104 679 | 8 052 839 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -270 | 35 068 | -0,76 | 230,98 | -62 365 | 8 100 007 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -953 | 35 338 | -2,63 | 230,00 | -219 190 | 8 127 740 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -3 156 | 36 291 | -8,00 | 239,23 | -755 010 | 8 681 896 | |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -249 | 39 447 | -0,63 | 245,82 | -61 209 | 9 696 862 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -720 | 39 696 | -1,78 | 245,15 | -176 508 | 9 731 474 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -540 | 40 416 | -1,32 | 244,08 | -131 803 | 9 864 737 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 260 | 40 956 | -2,98 | 242,85 | -305 991 | 9 946 165 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -720 | 42 216 | -1,68 | 242,04 | -174 269 | 10 217 961 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -3 262 | 42 936 | -7,06 | 241,50 | -787 773 | 10 369 044 | |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 46 198 | -0,86 | 248,73 | -99 492 | 11 490 829 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 103 | 46 598 | -4,32 | 247,98 | -521 502 | 11 555 372 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 821 | 48 701 | -3,60 | 246,88 | -449 568 | 12 023 303 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 320 | 50 522 | -7,88 | 245,99 | -1 062 677 | 12 427 907 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 426 | 54 842 | -5,88 | 245,05 | -839 541 | 13 439 032 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 000 | 58 268 | -1,69 | 243,53 | -243 530 | 14 190 006 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | -12 215 | 59 268 | -17,09 | 240,95 | -2 943 204 | 14 280 625 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 323 | 71 483 | 16,88 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 800 | 61 160 | 19,08 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 15 170 | 51 360 | 41,92 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 941 | 7 767 | -19,99 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 156 | 0 | -100,00 | ||||
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 36 190 | -1,09 | 232,87 | -93 148 | 8 427 565 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 177 | 36 590 | -3,12 | 231,92 | -272 970 | 8 485 953 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 306 | 37 767 | -3,34 | 231,25 | -302 012 | 8 733 619 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -714 | 39 073 | -1,79 | 230,07 | -164 270 | 8 989 525 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 39 787 | -1,24 | 228,89 | -114 445 | 9 106 846 |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 941 | 40 287 | 5,06 | 86,52 | 167 935 | 3 485 631 | |
2020-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 156 | 38 346 | 5,96 | 91,05 | 196 304 | 3 491 403 | |
2020-01-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -5 000 | 32 500 | -13,33 | ||||
2020-01-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 000 | 36 190 | -12,14 | 235,00 | -1 175 000 | 8 504 650 |
2020-01-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 41 190 | 13,82 | 109,14 | 545 700 | 4 495 477 | |
2020-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -5 000 | 37 500 | -11,76 | ||||
2020-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 000 | 36 190 | -12,14 | 230,00 | -1 150 000 | 8 323 700 |
2020-01-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 41 190 | 13,82 | 109,14 | 545 700 | 4 495 477 | |
2019-12-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -5 000 | 42 500 | -10,53 | ||||
2019-12-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 000 | 33 416 | -13,02 | 225,00 | -1 125 000 | 7 518 600 |
2019-12-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 38 416 | 14,96 | 109,14 | 545 700 | 4 192 722 | |
2019-11-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | -5 000 | 47 500 | -9,52 | ||||
2019-11-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 000 | 33 416 | -13,02 | 220,00 | -1 100 000 | 7 351 520 |
2019-11-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 38 416 | 14,96 | 109,14 | 545 700 | 4 192 722 | |
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -5 000 | 52 500 | -8,70 | ||||
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 000 | 33 416 | -13,02 | 215,00 | -1 075 000 | 7 184 440 |
2019-11-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 000 | 38 416 | 14,96 | 109,14 | 545 700 | 4 192 722 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -57 | 33 416 | -0,17 | 205,95 | -11 739 | 6 882 025 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 942 | 9 708 | -16,67 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 155 | 2 156 | -49,99 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 100 | 33 416 | -3,19 | 201,10 | -221 210 | 6 719 958 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 497 | 34 516 | -6,75 | 200,12 | -499 700 | 6 907 342 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 37 013 | -1,33 | 199,77 | -99 885 | 7 394 087 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 942 | 37 513 | 5,46 | 86,52 | 168 022 | 3 245 625 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 35 571 | 6,45 | 91,05 | 196 213 | 3 238 740 | |
2019-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -4 311 | 4 311 | -50,00 | ||||
2019-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 311 | 33 416 | -11,43 | 195,01 | -840 688 | 6 516 454 |
2019-10-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 311 | 37 727 | 12,90 | 91,05 | 392 517 | 3 435 043 | |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -3 883 | 11 650 | -25,00 | ||||
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 883 | 33 416 | -10,41 | 190,27 | -738 818 | 6 358 062 |
2019-10-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 883 | 37 299 | 11,62 | 86,52 | 335 957 | 3 227 109 | |
2019-05-30 |
|
4 | EIGR |
Eiger BioPharmaceuticals, Inc.
Stock Option ( Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2019-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -61 | 33 416 | -0,18 | 165,41 | -10 090 | 5 527 341 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 40 165 | -0,25 | 182,05 | -18 205 | 7 312 038 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 406 | 40 265 | -11,84 | 180,85 | -977 675 | 7 281 925 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -19 021 | 45 671 | -29,40 | 180,17 | -3 427 014 | 8 228 544 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -10 568 | 64 692 | -14,04 | 179,44 | -1 896 322 | 11 608 332 |
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 25 026 | 25 026 | |||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 799 | 75 260 | 14,97 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 126 | 65 461 | 18,30 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 298 | 55 335 | 45,48 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 155 | 8 622 | -20,00 | 91,05 | -196 213 | 785 033 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 942 | 15 533 | -11,11 | 86,52 | -168 022 | 1 343 915 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 625 | 38 037 | -8,70 | 187,30 | -678 962 | 7 124 330 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 000 | 41 662 | -10,72 | 186,55 | -932 750 | 7 772 046 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 035 | 46 662 | -2,17 | 187,23 | -193 783 | 8 736 526 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 120 | 47 697 | -2,29 | 186,52 | -208 902 | 8 896 444 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 817 | 4,62 | 91,05 | 196 213 | 4 444 788 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -742 | 46 662 | -1,57 | 187,35 | -139 014 | 8 742 126 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 200 | 47 404 | -2,47 | 186,57 | -223 884 | 8 844 164 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 942 | 48 604 | 4,16 | 86,52 | 168 022 | 4 205 218 | |
2018-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -61 | 46 662 | -0,13 | 163,75 | -9 989 | 7 640 902 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 1 941 | 17 475 | 12,50 | ||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -428 | 46 662 | -0,91 | 174,41 | -74 647 | 8 138 319 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 213 | 47 090 | -2,51 | 173,74 | -210 747 | 8 181 417 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 48 303 | -0,62 | 172,70 | -51 810 | 8 341 928 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 941 | 48 603 | 4,16 | 86,52 | 167 935 | 4 205 132 | |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 155 | 10 777 | 24,99 | ||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 46 662 | -0,21 | 176,04 | -17 604 | 8 214 378 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 46 762 | -0,21 | 175,31 | -17 531 | 8 197 846 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 46 862 | -0,21 | 173,35 | -17 335 | 8 123 528 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 255 | 46 962 | -2,60 | 172,81 | -216 877 | 8 115 503 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 48 217 | -1,23 | 171,93 | -103 158 | 8 289 949 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 817 | 4,62 | 91,05 | 196 213 | 4 444 788 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 942 | 19 416 | -9,09 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 46 662 | -0,21 | 176,69 | -17 669 | 8 244 709 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 46 762 | -1,47 | 175,86 | -123 102 | 8 223 565 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 142 | 47 462 | -2,35 | 174,50 | -199 279 | 8 282 119 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 942 | 48 604 | 4,16 | 86,52 | 168 022 | 4 205 218 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 155 | 12 932 | -14,28 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 46 662 | -0,64 | 179,38 | -53 814 | 8 370 230 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -355 | 46 962 | -0,75 | 178,49 | -63 364 | 8 382 247 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 47 317 | -0,84 | 176,95 | -70 780 | 8 372 743 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -400 | 47 717 | -0,83 | 175,88 | -70 352 | 8 392 466 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 48 117 | -1,43 | 175,06 | -122 542 | 8 423 362 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 817 | 4,62 | 91,05 | 196 213 | 4 444 788 | |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 719 | 0 | -100,00 | ||||
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -219 | 46 662 | -0,47 | 181,88 | -39 832 | 8 486 885 |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 500 | 46 881 | -3,10 | 180,14 | -270 210 | 8 445 143 |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 719 | 48 381 | 3,68 | 96,87 | 166 520 | 4 686 667 | |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -12 031 | 1 719 | -87,50 | ||||
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 031 | 46 662 | -20,50 | 180,00 | -2 165 580 | 8 399 160 |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 12 031 | 58 693 | 25,78 | 96,87 | 1 165 443 | 5 685 591 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 155 | 15 086 | -12,50 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 941 | 21 358 | -8,33 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 155 | 46 662 | -4,41 | 170,00 | -366 350 | 7 932 540 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 941 | 48 817 | -3,82 | 165,00 | -320 265 | 8 054 805 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 50 758 | 4,43 | 91,05 | 196 213 | 4 621 516 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 941 | 48 603 | 4,16 | 86,52 | 167 935 | 4 205 132 | |
2018-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -83 | 46 662 | -0,18 | 155,78 | -12 930 | 7 269 006 |
2018-03-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -13 750 | 13 750 | -50,00 | ||||
2018-03-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -13 750 | 46 662 | -22,76 | 175,00 | -2 406 250 | 8 165 850 |
2018-03-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 13 750 | 60 412 | 29,47 | 96,87 | 1 331 962 | 5 852 110 | |
2018-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 155 | 17 242 | -11,11 | ||||
2018-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 155 | 46 662 | -4,41 | 170,00 | -366 350 | 7 932 540 |
2018-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 817 | 4,62 | 91,05 | 196 213 | 4 444 788 | |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 46 662 | -0,64 | 153,92 | -46 176 | 7 182 215 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 400 | 46 962 | -2,89 | 153,25 | -214 550 | 7 196 926 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 100 | 48 362 | -2,22 | 152,26 | -167 486 | 7 363 598 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -7 296 | 49 462 | -12,85 | 151,22 | -1 103 301 | 7 479 644 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 200 | 56 758 | -5,34 | 150,44 | -481 408 | 8 538 674 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 500 | 59 958 | -6,98 | 149,22 | -671 490 | 8 946 933 |
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 23 479 | 23 479 | |||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 125 | 64 458 | 18,64 | ||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 15 170 | 54 333 | 38,74 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -2 578 | 0 | -100,00 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -1 942 | 23 299 | -7,69 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 242 | 39 163 | -5,41 | 164,93 | -369 773 | 6 459 154 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 41 405 | -1,43 | 163,79 | -98 274 | 6 781 725 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 42 005 | -0,71 | 161,93 | -48 579 | 6 801 870 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 42 305 | -0,70 | 160,97 | -48 291 | 6 809 836 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 42 605 | -1,62 | 159,93 | -111 951 | 6 813 818 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -378 | 43 305 | -0,87 | 158,55 | -59 932 | 6 866 008 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 578 | 43 683 | 6,27 | 77,31 | 199 305 | 3 377 133 | |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 942 | 41 105 | 4,96 | 86,52 | 168 022 | 3 556 405 | |
2018-01-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -15 085 | 19 397 | -43,75 | ||||
2018-01-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -15 085 | 39 163 | -27,81 | 170,00 | -2 564 450 | 6 657 710 |
2018-01-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 15 085 | 54 248 | 38,52 | 91,05 | 1 373 489 | 4 939 280 | |
2018-01-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -5 824 | 25 241 | -18,75 | ||||
2018-01-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -5 824 | 39 163 | -12,95 | 165,00 | -960 960 | 6 461 895 |
2018-01-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 824 | 44 987 | 14,87 | 86,52 | 503 892 | 3 892 275 | |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -13 750 | 0 | -100,00 | ||||
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -13 750 | 39 163 | -25,99 | 160,00 | -2 200 000 | 6 266 080 |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 13 750 | 52 913 | 35,11 | 83,36 | 1 146 200 | 4 410 828 | |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -13 750 | 13 750 | -50,00 | ||||
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -18 672 | 2 578 | -87,87 | ||||
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 39 163 | -1,76 | 159,35 | -111 545 | 6 240 624 |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -13 312 | 39 863 | -25,03 | 158,59 | -2 111 150 | 6 321 873 |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -18 410 | 53 175 | -25,72 | 157,67 | -2 902 705 | 8 384 102 |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 13 750 | 71 585 | 23,77 | 83,36 | 1 146 200 | 5 967 326 | |
2018-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 18 672 | 57 835 | 47,68 | 77,31 | 1 443 532 | 4 471 224 | |
2017-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -83 | 50 710 | -0,16 | 147,29 | -12 225 | 7 469 076 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -100 | 50 710 | -0,20 | 149,34 | -14 934 | 7 573 031 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 000 | 50 810 | -1,93 | 148,35 | -148 350 | 7 537 664 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 200 | 51 810 | -4,07 | 147,70 | -324 940 | 7 652 337 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 200 | 54 010 | -5,59 | 146,53 | -468 896 | 7 914 085 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 438 | 57 210 | -17,86 | 145,26 | -1 806 744 | 8 310 325 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -17 362 | 69 648 | -19,95 | 144,47 | -2 508 288 | 10 062 047 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 800 | 87 010 | -3,12 | 143,49 | -401 772 | 12 485 065 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -900 | 89 810 | -0,99 | 142,40 | -128 160 | 12 788 944 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 564 | 90 710 | -1,69 | 162,07 | -253 477 | 14 701 370 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 461 | 92 274 | -4,61 | 161,44 | -720 184 | 14 896 715 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -500 | 96 735 | -0,51 | 160,04 | -80 020 | 15 481 469 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 300 | 97 235 | -1,32 | 158,90 | -206 570 | 15 450 642 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -800 | 98 535 | -0,81 | 158,05 | -126 440 | 15 573 457 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | 20 000 | 21 250 | 1 600,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -20 000 | 99 335 | -16,76 | 161,00 | -3 220 000 | 15 992 935 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 119 335 | 20,13 | 77,31 | 1 546 200 | 9 225 789 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -30 500 | 0 | -100,00 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -30 500 | 99 335 | -23,49 | 125,00 | -3 812 500 | 12 416 875 |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 30 500 | 129 835 | 30,70 | 51,75 | 1 578 375 | 6 718 961 | |
2017-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -116 | 99 335 | -0,12 | 114,37 | -13 267 | 11 360 944 |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -28 593 | 0 | -100,00 | 45,11 | -1 289 830 | ||
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -29 032 | 0 | -100,00 | 48,74 | -1 415 020 | ||
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -17 156 | 0 | -100,00 | 37,86 | -649 526 | ||
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | -5 719 | 0 | -100,00 | 38,80 | -221 897 | ||
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -29 032 | 99 335 | -22,62 | 110,00 | -3 193 520 | 10 926 850 |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -51 468 | 128 367 | -28,62 | 106,30 | -5 471 048 | 13 645 412 |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 28 593 | 179 835 | 18,91 | 45,11 | 1 289 830 | 8 112 357 | |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 29 032 | 151 242 | 23,76 | 48,74 | 1 415 020 | 7 371 535 | |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 17 156 | 122 210 | 16,33 | 37,86 | 649 526 | 4 626 871 | |
2017-03-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 719 | 105 054 | 5,76 | 38,80 | 221 897 | 4 076 095 | |
2017-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -7 684 | 99 335 | -7,18 | 87,68 | -673 733 | 8 709 693 |
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 31 065 | 31 065 | |||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 15 170 | 107 019 | 16,52 | ||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 753 | 91 849 | 6,68 | 0,01 | 58 | 918 | |
2016-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -116 | 86 096 | -0,13 | 93,36 | -10 830 | 8 037 923 |
2016-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -117 | 86 096 | -0,14 | 81,67 | -9 555 | 7 031 460 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 266 | 86 096 | -1,45 | 92,79 | -117 472 | 7 988 848 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -900 | 87 362 | -1,02 | 91,82 | -82 638 | 8 021 579 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 700 | 88 262 | -4,02 | 91,01 | -336 737 | 8 032 725 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 300 | 91 962 | -4,47 | 89,91 | -386 613 | 8 268 303 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 34 482 | 34 482 | |||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 299 | 96 262 | 21,91 | 0,01 | 173 | 963 | |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -85 | 78 963 | -0,11 | 122,28 | -10 394 | 9 655 596 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 100 | 78 963 | -1,37 | 126,61 | -139 271 | 9 997 505 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 638 | 80 063 | -3,19 | 126,01 | -332 414 | 10 088 739 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 500 | 82 701 | -1,78 | 124,94 | -187 410 | 10 332 663 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -700 | 84 201 | -0,82 | 123,34 | -86 338 | 10 385 351 |
2015-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 34 000 | 34 000 | |||||
2015-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -131 | 84 901 | -0,15 | 123,85 | -16 224 | 10 514 989 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -200 | 84 901 | -0,24 | 127,90 | -25 580 | 10 858 838 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -600 | 85 101 | -0,70 | 127,16 | -76 296 | 10 821 443 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 200 | 85 701 | -2,50 | 125,93 | -277 046 | 10 792 327 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -1 783 | 87 901 | -1,99 | 125,07 | -223 000 | 10 993 778 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -300 | 89 684 | -0,33 | 122,78 | -36 834 | 11 011 402 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -10 532 | 28 593 | -26,92 | ||||
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -1 468 | 29 032 | -4,81 | ||||
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 000 | 89 984 | -11,77 | 135,08 | -1 620 960 | 12 155 039 |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 532 | 101 984 | 11,52 | 45,11 | 475 099 | 4 600 498 | |
2015-03-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 468 | 91 452 | 1,63 | 48,74 | 71 550 | 4 457 370 | |
2015-03-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -6 625 | 39 125 | -14,48 | ||||
2015-03-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -5 375 | 0 | -100,00 | ||||
2015-03-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 000 | 89 984 | -11,77 | 130,00 | -1 560 000 | 11 697 920 |
2015-03-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 6 625 | 101 984 | 6,95 | 45,11 | 298 854 | 4 600 498 | |
2015-03-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 375 | 95 359 | 5,97 | 39,05 | 209 894 | 3 723 769 | |
2015-02-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -3 137 | 89 984 | -3,37 | 113,14 | -354 920 | 10 180 790 |
2015-02-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 800 | 93 121 | -2,92 | 112,62 | -315 336 | 10 487 287 |
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
A - Award | 57 500 | 57 500 | |||||
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 250 | 95 921 | 21,93 | 0,01 | 172 | 959 | |
2015-01-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -12 000 | 5 375 | -69,06 | ||||
2015-01-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 000 | 78 671 | -13,23 | 125,00 | -1 500 000 | 9 833 875 |
2015-01-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 12 000 | 90 671 | 15,25 | 39,05 | 468 600 | 3 540 703 | |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -12 000 | 17 375 | -40,85 | ||||
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 000 | 78 671 | -13,23 | 120,00 | -1 440 000 | 9 440 520 |
2014-12-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 12 000 | 90 671 | 15,25 | 39,05 | 468 600 | 3 540 703 | |
2014-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -134 | 78 671 | -0,17 | 111,97 | -15 004 | 8 808 792 |
2014-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 40 000 | 78 671 | 103,44 | 0,01 | 400 | 787 | |
2014-10-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -12 000 | 29 375 | -29,00 | ||||
2014-10-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -12 000 | 38 671 | -23,68 | 115,00 | -1 380 000 | 4 447 165 |
2014-10-30 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 12 000 | 50 671 | 31,03 | 39,05 | 468 600 | 1 978 703 | |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -28 594 | 17 156 | -62,50 | ||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -40 031 | 5 719 | -87,50 | ||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -10 500 | 0 | -100,00 | ||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -4 375 | 41 375 | -9,56 | ||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -2 500 | 0 | -100,00 | ||||
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -17 247 | 38 671 | -30,84 | 113,91 | -1 964 606 | 4 405 014 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -22 646 | 55 918 | -28,82 | 113,13 | -2 561 942 | 6 326 003 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -34 753 | 78 564 | -30,67 | 112,22 | -3 899 982 | 8 816 452 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -11 354 | 113 317 | -9,11 | 111,33 | -1 264 041 | 12 615 582 |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 28 594 | 124 671 | 29,76 | 37,86 | 1 082 569 | 4 720 044 | |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 40 031 | 96 077 | 71,43 | 38,80 | 1 553 203 | 3 727 788 | |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 500 | 56 046 | 23,05 | 33,82 | 355 110 | 1 895 476 | |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 375 | 45 546 | 10,63 | 39,05 | 170 844 | 1 778 571 | |
2014-10-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 500 | 41 171 | 6,46 | 33,28 | 83 200 | 1 370 171 | |
2014-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 27 500 | 27 500 | |||||
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -20 000 | 10 500 | -65,57 | ||||
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -7 000 | 2 500 | -73,68 | ||||
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | -15 250 | 0 | -100,00 | ||||
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -42 250 | 38 671 | -52,21 | 98,03 | -4 141 768 | 3 790 918 |
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 20 000 | 80 921 | 32,83 | 33,82 | 676 400 | 2 736 748 | |
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 000 | 60 921 | 12,98 | 33,28 | 232 960 | 2 027 451 | |
2014-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 15 250 | 53 921 | 39,44 | 33,55 | 511 638 | 1 809 050 | |
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 41 250 | 41 250 | |||||
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 875 | 38 436 | 44,71 | 0,01 | 119 | 384 | |
2013-12-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 542 | 26 561 | -8,73 | 65,47 | -166 425 | 1 738 949 |
2013-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 27 500 | 27 500 | |||||
2013-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -15 250 | 15 250 | -50,00 | ||||
2013-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -7 000 | 9 500 | -42,42 | ||||
2013-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -15 250 | 28 987 | -34,47 | 89,00 | -1 357 250 | 2 579 843 |
2013-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -7 000 | 44 237 | -13,66 | 88,00 | -616 000 | 3 892 856 |
2013-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 15 250 | 51 237 | 42,38 | 33,55 | 511 638 | 1 719 001 | |
2013-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 000 | 35 987 | 24,15 | 33,28 | 232 960 | 1 197 647 | |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -30 500 | 30 500 | -50,00 | ||||
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -7 000 | 16 500 | -29,79 | ||||
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -15 250 | 28 987 | -34,47 | 87,00 | -1 326 750 | 2 521 869 |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -7 000 | 44 237 | -13,66 | 86,00 | -602 000 | 3 804 382 |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -15 250 | 51 237 | -22,94 | 85,00 | -1 296 250 | 4 355 145 |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 000 | 66 487 | 11,77 | 33,28 | 232 960 | 2 212 687 | |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 30 500 | 59 487 | 105,22 | 33,55 | 1 023 275 | 1 995 789 | |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -7 000 | 23 500 | -22,95 | ||||
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -7 000 | 28 987 | -19,45 | 84,00 | -588 000 | 2 434 908 |
2013-07-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 7 000 | 35 987 | 24,15 | 33,28 | 232 960 | 1 197 647 | |
2013-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -60 000 | 0 | -100,00 | ||||
2013-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -1 907 | 0 | -100,00 | ||||
2013-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -47 507 | 28 987 | -62,11 | 81,45 | -3 869 445 | 2 360 991 |
2013-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -14 400 | 76 494 | -15,84 | 80,65 | -1 161 360 | 6 169 241 |
2013-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 60 000 | 90 894 | 194,21 | 33,00 | 1 980 000 | 2 999 502 | |
2013-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 907 | 30 894 | 6,58 | 32,16 | 61 329 | 993 551 | |
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 45 750 | 45 750 | |||||
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 166 | 28 987 | 54,01 | 0,01 | 102 | 290 | |
2012-11-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -2 287 | 18 821 | -10,83 | 41,29 | -94 430 | 777 119 |
2012-09-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | -9 531 | 1 907 | -83,33 | ||||
2012-09-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -9 531 | 21 108 | -31,11 | 59,00 | -562 329 | 1 245 372 |
2012-09-25 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 9 531 | 30 639 | 45,15 | 32,16 | 306 517 | 985 350 | |
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | -9 531 | 11 438 | -45,45 | ||||
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -9 531 | 21 108 | -31,11 | 58,00 | -552 798 | 1 224 264 |
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 9 531 | 30 639 | 45,15 | 32,16 | 306 517 | 985 350 | |
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | -9 531 | 20 969 | -31,25 | ||||
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
M - Exercise | -18 750 | 0 | -100,00 | ||||
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -18 637 | 21 108 | -46,89 | 56,50 | -1 052 990 | 1 192 602 |
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -19 644 | 39 745 | -33,08 | 55,86 | -1 097 314 | 2 220 156 |
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 9 531 | 59 389 | 19,12 | 32,16 | 306 517 | 1 909 950 | |
2012-09-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 18 750 | 49 858 | 60,27 | 29,25 | 548 438 | 1 458 346 | |
2012-07-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 30 500 | 30 500 | |||||
2012-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -56 250 | 18 750 | -75,00 | ||||
2012-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -58 750 | 31 108 | -65,38 | 52,13 | -3 062 638 | 1 621 660 |
2012-05-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 56 250 | 89 858 | 167,37 | 29,25 | 1 645 312 | 2 628 346 | |
2012-04-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
M - Exercise | -19 062 | 0 | -100,00 | ||||
2012-04-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -26 562 | 33 608 | -44,14 | 41,01 | -1 089 308 | 1 378 264 |
2012-04-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 19 062 | 60 170 | 46,37 | 18,93 | 360 844 | 1 139 018 | |
2012-02-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 066 | 41 108 | -9,00 | 36,81 | -149 669 | 1 513 185 |
2012-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 45 750 | 45 750 | |||||
2012-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 10 166 | 45 174 | 29,04 | 0,01 | 102 | 452 | |
2012-01-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | -4 066 | 35 008 | -10,41 | 37,00 | -150 442 | 1 295 296 |